Research > Focus D > Work Packages D01
Summary
This central project aims at ensuring uniform availability and quality of tissue material and high-throughput data in cost-effective and state-of-technology way to be used in UNITE subprojects (coined UNITE Core Collection). Our aim is to work with and provide material and data from newly diagnosed patients and matching recurrences, which has been stringently standardized, characterized and anaylzed reflecting the multilevel approach of the CRC. The visual abstract below shows the aims and planned tasks of the work package.
Task 1
Tumor banking and clinical data management in Heidelberg and Mannheim
Steps / Workflow
- Obtaining patient consent
- Archiving tumor tissue
- Quality control
- Preparing tumor sections, RNA, DNA and proteins
- Assessing clinical data
Task 2
Preparation of cell isolates and primary cell cultures
Steps / Workflow
- Preparing single cell suspensions from tumor tissues for functional analyses, PDX models, primary cultures and further sorting of distinct cell populations
- Establishing primary cultures
Task 3
Molecular characterization of tumors and primary cell culture UNITE Core Collection
Steps / Workflow
- 100 newly diagnosed glioblastoma samples and 20 matching recurrences, for which we will establish an uniform data matrix, consisting of epigenome analysis, whole-genome sequencing, RNA sequencing, single cell sequencing, data on a set of currently relevant biomarkers, and metabolomics and proteomic profiling as well as fully characterized PDX of >30%
Task 4
Proteomics
Steps / Workflow
- Development and implementation of protocols for identification and quantification of proteins extracted from FFPE tissue
- Development and implementation of protocols for identification and quantification of protein modifications on fresh frozen tissue
VON DEIMLING, ANDREAS, PROF. DR. MED.
University Hospital Heidelberg, Institute of Pathology, Department of Neuropathology & DKFZ, Clinical Cooperation Unit Neuropathology, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany
HEROLD-MENDE, CHRISTEL, PROF. DR. RER. NAT.
University Hospital Heidelberg, Department of Neurosurgery, Division of Neurosurgical Research, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
Ratliff, Miriam, Dr.med., Dipl.-Biol.
University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University Theodor-Kutzer-Ufer 1-3, 68167 Mannheim
Address
Im Neuenheimer Feld 400
69120 Heidelberg
Themen
Research
- Focus A
- A01: Targeting tumor cell networks to overcome primary and adaptive resistance in glioblastoma
- A02: Development of a specific combination therapy for histone H3-mutant pediatric glioblastoma
- A03: Deciphering resistance against targeted treatments
- A04: Evolution of IDH mutant gliomas during malignant progression
- A05: Predictive biomarkers for MGMT-promoter-methylated glioblastoma
- A06: Resistance mechanisms of glioblastoma against alkylating agents and radiotherapy
Research
- Focus B
- B01: Mechanisms of response and resistance to checkpoint blockade in gliomas
- B02: DNA mis-match repair regulates immune checkpoint blockade therapy in glioblastoma
- B03: Targeting immunosuppressive programs in isocitrate dehydrogenase mutant gliomas
- B04: Impact of myeloid cells on the adaptive immune response in IDH1-mutant glioblastomas
- B05: Dissecting the response of glioblastoma and its tumor microenvironment to focused high-dose radiotherapy
Research
- Focus C
- C01: Comprehensive preclinical pharmacology testing of drugs used for glioblastoma treatment in children and adults
- C02: Radiomics, radiogenomics and deep-learning in neurooncology
- C03: Imaging immune signatures of glioma response and resistance towards immunotherapy
- C04: Identification and spatial mapping of metabolic resistance factors by MALDI mass spectrometry imaging
- C05: Overcoming glioma radio-resistance with particle therapy